“Pembrolizumab-Associated Anti-MDA5 Dermatomyositis in a Patient With Lung Cancer: A First Case Report”. Swiss Medical Weekly 154, no. 3 (March 4, 2024): 3513. Accessed October 14, 2025. https://www.smw.ch/index.php/smw/article/view/3513.